Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports.

{
  "signal_id": "90df6c29-5c57-4950-8f04-918779be9c23",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-06-07T09:11:03+00:00",
  "company": {
    "name": "Incyte",
    "domain": "incyte.com"
  },
  "data": {
    "url": "https://srnnews.com/incyte-nears-up-to-2-billion-deal-for-blood-disorder-biotech-star-ft-reports",
    "title": "Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports.",
    "ticker": "NASDAQ:INCY",
    "excerpt": "Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports.\n\nJune 7 (Reuters) - US biotech Incyte Pharma is nearing a deal for up to $2 billion to buy blood disorder drug developer Star Therapeutics, the Financial Times reported on Sunday, citing people familiar with the matter.\n\nThe biotechnology company is set to pay $1.25 billion upfront in cash to Star's venture capital backers and a further $750 million based on certain performance milestones being met, the report said.\n\nReuters could not immediately verify the report.\n\n(Reporting by Preetika Parashuraman in BengaluruEditing by Tomasz Janowski)",
    "summary": "Incyte Corporation acquired Star Therapeutics, Inc. for $2B on Jun 7th '26.",
    "location": "United States, Northern America, Americas",
    "planning": false,
    "image_url": "https://www.srnnews.com/media/2025/11/srnnews-site-image.png?x97605",
    "confidence": 0.8629,
    "published_at": "2026-06-07T09:11:03Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-07",
    "article_sentence": "June 7 (Reuters) - US biotech Incyte Pharma is nearing a deal for up to $2 billion to buy blood disorder drug developer Star Therapeutics, the Financial Times reported on Sunday, citing people familiar with the matter.",
    "amount_normalized": 2000000000,
    "related_company_name": "Star Therapeutics, Inc.",
    "related_company_domain": "star-therapeutics.com"
  }
}

curl https://signals.autobound.ai/v1/signals/90df6c29-5c57-4950-8f04-918779be9c23 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"incyte.com","limit":20}'